Infectious Disease

Researchers modeled how existing vaccines could slow the rare Bundibugyo outbreak in the Congo. Their findings show vaccination works best alongside robust case detection and contact tracing.

Stanford Medicine’s David Relman transformed clinical diagnostics and food tracing for cyclospora, the parasitic organism behind the surge of this diarrheal illness. Here’s what he thinks you should know.

A new Stanford-led study finds dengue cases surged 400% near a newly paved highway in the Peruvian Amazon, with implications as more roads are planned in remote areas worldwide.

A federal grant launches the Center for Phage Pharmaceuticals, which will develop bacteriophage therapies to defeat antibiotic-resistant “superbugs” increasingly common in hospitals.

Stanford global health expert Michele Barry shares essential facts.

Hantavirus is rare and unable to cause a global pandemic, says Jorge Salinas, medical director of infection prevention at Stanford Health Care.

The host-targeted approach of Shirit Einav’s lab could revolutionize antiviral development, creating broad-spectrum drugs resistant to viral mutation.

As warming temperatures spread dengue to new regions, Stanford researchers are using drones and artificial intelligence to hunt down hidden mosquito breeding sites.

A Stanford study reveals how testing and treatment strategies have the potential to cut HCV infections by nearly half among people who inject drugs, offering a cost-effective public health approach.

New Stanford-led research traces a direct line from extreme weather to a massive dengue outbreak in Peru. The findings serve as a warning – and the seed of a possible solution.